| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 02/05/2003 | EP1280555A2 Treatment of congestive heart failure with a composition comprising a diuretic agent and a vasopressin antagonist |
| 02/05/2003 | EP1037868B1 $g(a)-HYDROXY, -AMINO, AND HALO DERIVATIVES OF $g(b)-SULFONYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASES INHIBITORS |
| 02/05/2003 | EP0730616B1 Process for preparing polyazamacrocycles |
| 02/05/2003 | CN1395566A Corticotropin releasing factor antagonists |
| 02/05/2003 | CN1395563A Isatine derivatives with neurotrophic activity |
| 02/05/2003 | CN1395562A Nitrogenous cyclic compounds and pharmaceutical compositions containing the same |
| 02/05/2003 | CN1395467A Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents |
| 02/05/2003 | CN1394864A Metallophenyl cyclopentadienyl phthalocyanine derivative, its preparation method and application |
| 02/05/2003 | CN1394861A Meso-tetra (2,5-difluorophenyl) porphyrin containing fluoroporphyrin developer, its synthesis and application |
| 02/05/2003 | CN1100779C 3-aryl substituted pyrazolo [4,3-d] pyriidine derivatives, corticotropin-releasing factor receptor (CRF1) specific ligands |
| 02/05/2003 | CN1100778C Pyrrolopyriidines and processes for preapring thereof |
| 02/04/2003 | US6515135 Aminoaryl oxazolidinone N-oxides |
| 02/04/2003 | US6515122 Tetracyclic benzimidazole derivatives and combinatorial libraries thereof |
| 02/04/2003 | US6515113 Phthalamide lanthanide complexes for use as luminescent markers |
| 02/04/2003 | US6514982 CRF receptor antagonists and methods relating thereto |
| 02/04/2003 | US6514977 For treating p38 kinase mediated disorders |
| 02/04/2003 | US6514972 Heteropolycyclic inhibitors of protein kinases |
| 02/04/2003 | US6514964 Treating diseases, conditions or disorders mediated by integrin receptors, such as vitronectin and fibronectin receptors |
| 02/04/2003 | US6514934 For treating sexual dysfunctions in males and females |
| 02/04/2003 | US6514665 Additives for improving post exposure delay stability of photoresist |
| 02/04/2003 | CA2290766C Method of treating nitrate-induced tolerance |
| 01/30/2003 | WO2003008430A2 Porphyrin derivatives for photodynamic therapy |
| 01/30/2003 | WO2003008421A1 Process for preparation of amidine derivatives |
| 01/30/2003 | WO2003008418A1 Imidazo-triazine derivatives as ligands for gaba receptors |
| 01/30/2003 | WO2003008417A1 Substituted 6-(2-tolyl)-triazolopyrimidines as fungicides |
| 01/30/2003 | WO2003008416A1 Substituted 6-(2-methoxyphenyl) triazolopyrimides as fungicides |
| 01/30/2003 | WO2003008415A1 6-(2,6-difluorophenyl)-triazolopyrimidines as fungicides |
| 01/30/2003 | WO2003008410A2 Polypyrroles as agents for treating cancer, treating viral diseases and causing immunosuppression |
| 01/30/2003 | WO2003008405A1 Compounds derived from diaminopyrazole substituted by a heteroaromatic radical and their use in oxidation dyeing of keratinous fibres |
| 01/30/2003 | WO2003007966A1 Active substance combination for medicamentous therapy of nicotine dependency |
| 01/30/2003 | WO2002088079A3 Dual inhibitors of pde 7 and pde 4 |
| 01/30/2003 | WO2002068422A3 Syntheses for preparing 1,4-diketopyrrolo[3,4-c]pyrroles |
| 01/30/2003 | WO2002060449A3 Pharmaceutical formulation containing pyrazolo[4,3-d]pyrimidine and nitrates or thienopyrimidines and nitrates |
| 01/30/2003 | WO2002047679A8 Nonpeptide agonists and antagonists of vasopressin receptors |
| 01/30/2003 | WO2002014536A3 Odulating multiple lineage kinase proteins |
| 01/30/2003 | WO2002012247A1 Method for the production of imidazo-(1,2-c)(2,3)-benzodiazepines and intermediates in the production thereof |
| 01/30/2003 | WO2002000617A3 Selective androgen receptor modulators and methods for their identification, design and use |
| 01/30/2003 | US20030023097 Fluorescent materials and their use |
| 01/30/2003 | US20030023087 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use |
| 01/30/2003 | US20030023081 Water-soluble porphyrin derivatives for photodynamic therapy, their use and manufacture |
| 01/30/2003 | US20030022914 Nitric oxide synthase inhibitors |
| 01/30/2003 | US20030022905 Prevention and/or therapy of ischaemia and reperfusion damage; poly(ADP-ribose)-synthetase inhibitors |
| 01/30/2003 | US20030022898 Methods of treating inflammatory and immune diseases using inhibitors of IkappaB kinase (IKK) |
| 01/30/2003 | US20030022894 Imidazotriazinone-containing compositions for nasal administration |
| 01/30/2003 | US20030022891 Melanin-concentrating hormone (MCH); treating metabolic and eating disorders, such as hyperphagia, and diabetes; urea, thiourea and cyano-guanidine compounds of given formula |
| 01/30/2003 | US20030022890 Heterocyclic dihydropyrimidine compounds |
| 01/30/2003 | US20030022885 Pyrazole compounds useful as protein kinase inhibitors |
| 01/30/2003 | US20030022883 Poly(adenosine 5'-diphospho-ribose) polymerase (PARP) inhibitors; compounds based on thieno(4,3,2-ef)(2)benzazepin-6-one |
| 01/30/2003 | US20030021755 Headache therapy |
| 01/30/2003 | US20030021754 Aerosols; vaporization, cooling |
| 01/30/2003 | US20030021753 Delivery of antiemetics through an inhalation route |
| 01/30/2003 | CA2453997A1 Porphyrin derivatives for photodynamic therapy |
| 01/30/2003 | CA2453664A1 Process for preparation of amidine derivatives |
| 01/30/2003 | CA2453639A1 Substituted 6-(2-tolyl)-triazolopyrimidines as fungicides |
| 01/30/2003 | CA2453638A1 6-(2,6-difluorophenyl)-triazolopyrimidines as fungicides |
| 01/30/2003 | CA2453636A1 Polypyrroles as agents for treating cancer, treating viral diseases and causing immunosuppression |
| 01/30/2003 | CA2451445A1 Imidazo-triazine derivatives as ligands for gaba receptors |
| 01/30/2003 | CA2417804A1 Method for the production of imidazo-(1,2-c)(2,3)-benzodiazepines and intermediates in the production thereof |
| 01/29/2003 | EP1279676A1 Porphyrin derivatives for photodynamic therapy |
| 01/29/2003 | EP1279519A2 Image forming material and ammonium compound |
| 01/29/2003 | EP1278751A1 Tricyclic fused pyridine and pyrimidine derivatives as crf receptor antagonists |
| 01/29/2003 | EP1278750A1 Imidazopyrimidine derivatives and triazolopyrimidine derivatives |
| 01/29/2003 | EP1278749A1 USE OF 5-THIO-, SULFINYL- AND SULFONYLPYRAZOLO 3,4-b]-PYRIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS |
| 01/29/2003 | EP1278748A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 01/29/2003 | EP1278741A1 Muscarinic agonists |
| 01/29/2003 | EP1210349B1 PYRAZOLO 4,3-d]PYRIMIDINES |
| 01/29/2003 | EP1178990B1 Imidazodiazepine derivative |
| 01/29/2003 | EP1129097B1 Novel type condensed pyridazinone compounds |
| 01/29/2003 | EP0835243B1 Dialkyl phenyl halide-substituted keto-enols for use as herbicides and pesticides |
| 01/29/2003 | CN1393445A Process for synthesizing phthalooyanine by microwave method |
| 01/29/2003 | CN1393444A Compound for treating impotence |
| 01/29/2003 | CN1099869C Photosensibilizers |
| 01/28/2003 | US6512114 Process for the preparation of Midazolam |
| 01/28/2003 | US6512112 Useful as prodrugs, easily convert to parent amine in vivo; antibiotic activity versus gram negative aerobic and anaerobic bacteria |
| 01/28/2003 | US6512111 A method for preparing compounds of formula (I) ) wherein cyclization is carried out in a basic medium and in the presence of a phosphonic acid derivative and the use of said method as an intermediate step for preparing a compound |
| 01/28/2003 | US6511987 Heterocyclic derivatives that bind to the benzodiazepine site of GABAA receptors for treatment of central nervous system disorders |
| 01/28/2003 | US6511974 Non-peptidic and have good oral bioavailability, specific vasopressin V2 agonists, therefore do not raise blood pressure |
| 01/28/2003 | US6511971 Substituted perhalogenated phthalocyanines |
| 01/28/2003 | CA2307101C Pharmaceutical articles of manufacture comprising selective phosphodiesterase inhibitors for the treatment of sexual dysfunction |
| 01/28/2003 | CA2123124C Photosensitizers |
| 01/23/2003 | WO2003006563A1 A compressed fluid formulation |
| 01/23/2003 | WO2003006507A1 Method of preparing antinarcotic shellfish toxin antibody, novel antibody, elisa kit with the use of the antibody and labelled toxin sample prepared by the method |
| 01/23/2003 | WO2003006471A1 Heteroaryl substituted fused bicyclic heteroaryl compounds as gabaa receptor ligands |
| 01/23/2003 | WO2003006466A1 Hexahydroazepino (4, 5-g) indoles and indolines as 5-ht receptor ligands |
| 01/23/2003 | WO2003006423A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 01/23/2003 | WO2003006024A1 Medicine containing pyrimidine derivative |
| 01/23/2003 | WO2002050066A3 Pyrazole compounds useful as protein kinase inhibitors |
| 01/23/2003 | US20030018189 Cyclic polyamines having total 9-24 members which have activity in against HIV-infected cells as well as other biological activity related to binding of ligands to chemokine receptors |
| 01/23/2003 | US20030018059 Antiinflammatory agents; antihistamines; antiallergens |
| 01/23/2003 | US20030018038 1,4 substituted piperidinyl NMDA/NR2B antagonists |
| 01/23/2003 | US20030018032 Bicyclic imidazo-3-yl-amine derivatives |
| 01/23/2003 | US20030018026 Preterm labor; urogenital disorders; fertility; psychological disorders |
| 01/23/2003 | US20030018025 Psychological disorders, antidepressants, Parkinson's disease |
| 01/23/2003 | US20030018024 Biphenyl vasopressin agonists |
| 01/23/2003 | US20030018023 5-6 or 5-7 Heterobicycles as Factor Xa inhibitors |
| 01/23/2003 | US20030017941 Catalysts and methods for catalytic oxidation |
| 01/23/2003 | US20030017164 Dye-azide compounds for dual phototherapy |
| 01/23/2003 | US20030017120 Delivery of erectile dysfunction drugs through an inhalation route |
| 01/23/2003 | US20030017119 Aerosol comprises particles comprising at least 10 percent by weight of an opioid, and wherein the opioid is not heroin; opiods include morphine, codeine, naltrexone, buprenorphine, fentanyl, nalbuphine, naloxone, etc. |
| 01/23/2003 | US20030017118 An aerosol for inhalation therapy, wherein the aerosol comprises particles comprising at least 10 percent by weight of an antipsychotic such as olanzapine, trifluoperazine, haloperidol, loxapine, clozapine, quetiapine, promazine, etc. |